Science Magazine· @ScienceMagazine · X·· 7 天前精选AI 评分58
AI 导读
研究团队首次将受体基因疗法植入人脑,通过药物调控神经元活动,用于3名耐药性癫痫患者,抑制其海马区癫痫发作区域的异常活动。开展该临床试验的团队报告,疗法未产生重大副作用,并似有降低癫痫发作频率的效果。
推荐理由
该试验把化学遗传学受体基因治疗用于耐药性癫痫患者,读者可据此了解这一调控神经活动的新路径及其初步安全性信号。
正文
Researchers have, for the first time, inserted receptors into the human brain that allow them to manipulate neuron activity with a drug.
The groundbreaking gene therapy was designed to help three people with drug-resistant epilepsy by dampening activity in the seizure-generating zones of their hippocampus.
The therapy did not produce major side effects, and appeared to reduce the incidence of seizures, the team conducting the clinical trial reported.
Learn more: https://scim.ag/4zkx35K @NewsfromScience
来源:Science Magazine · x.com